Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

214 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gastrointestinal Biomarkers and Their Association with Feeding in the First Five Days of Pediatric Critical Illness.
Veldscholte K, Hulst JM, Eveleens RD, de Jonge RCJ, de Koning BAE, van den Berg SAA, van der Wal R, Ruijter GJG, Rizopoulos D, Vanhorebeek I, Gunst J, Casaer M, Van den Berghe G, Joosten KFM, Verbruggen SCAT. Veldscholte K, et al. Among authors: rizopoulos d. J Pediatr Gastroenterol Nutr. 2023 Dec 1;77(6):811-818. doi: 10.1097/MPG.0000000000003950. Epub 2023 Sep 20. J Pediatr Gastroenterol Nutr. 2023. PMID: 37728917 Free PMC article. Clinical Trial.
Intermittent feeding with an overnight fast versus 24-h feeding in critically ill neonates, infants, and children: An open-label, single-centre, randomised controlled trial.
Veldscholte K, Cramer ABG, de Jonge RCJ, Rizopoulos D, Joosten KFM, Verbruggen SCAT. Veldscholte K, et al. Among authors: rizopoulos d. Clin Nutr. 2023 Sep;42(9):1569-1580. doi: 10.1016/j.clnu.2023.07.010. Epub 2023 Jul 15. Clin Nutr. 2023. PMID: 37478810 Free article. Clinical Trial.
Randomised clinical trial: First-line infliximab biosimilar is cost-effective compared to conventional treatment in paediatric Crohn's disease.
Vuijk SA, Jongsma MME, Hoeven BM, Cozijnsen MA, van Pieterson M, de Meij TGJ, Norbruis OF, Groeneweg M, Wolters VM, van Wering H, Hummel T, Stapelbroek J, van der Feen C, van Rheenen PF, van Wijk MP, Teklenburg S, Rizopoulos D, Poley MJ, Escher JC, de Ridder L. Vuijk SA, et al. Among authors: rizopoulos d. Aliment Pharmacol Ther. 2024 Apr 21. doi: 10.1111/apt.18000. Online ahead of print. Aliment Pharmacol Ther. 2024. PMID: 38644588
Long term survival in patients with classic infantile Pompe disease reveals a spectrum with progressive brain abnormalities and changes in cognitive functioning.
van den Dorpel JJA, Mackenbach MJ, Dremmen MHG, van der Vlugt WMC, Rizopoulos D, van Doorn PA, van der Ploeg AT, Muetzel R, van der Beek NAME, van den Hout JMP. van den Dorpel JJA, et al. Among authors: rizopoulos d. J Inherit Metab Dis. 2024 Apr 8. doi: 10.1002/jimd.12736. Online ahead of print. J Inherit Metab Dis. 2024. PMID: 38584574
Rare and severe adverse events in children with inflammatory bowel disease: analysis of data from the PIBD-SETQuality Safety Registry.
Klomberg RCW, Hellendoorn AE, Kemos P, Rizopoulos D, Ruemmele FM, Croft NM, de Ridder L; PIBD-SETQuality Safety Registry collaborators. Klomberg RCW, et al. Among authors: rizopoulos d. Lancet Child Adolesc Health. 2024 Jun;8(6):422-432. doi: 10.1016/S2352-4642(24)00078-6. Epub 2024 Apr 30. Lancet Child Adolesc Health. 2024. PMID: 38697175
214 results